These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38994815)

  • 1. Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma.
    Lever M; Bogner S; Giousmas M; Mairinger FD; Baba HA; Richly H; Gromke T; Schuler M; Bechrakis NE; Kalkavan H
    Pigment Cell Melanoma Res; 2024 Jul; ():. PubMed ID: 38994815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of liver metastases from uveal melanoma.
    Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
    Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
    Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion.
    Ludwig JM; Haubold J; Bauer S; Richly H; Siveke JT; Wimmer J; Umutlu L; Schaarschmidt BM; Theysohn JM
    Radiol Oncol; 2021 May; 55(3):347-353. PubMed ID: 34051707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic uveal melanoma: The final frontier.
    Rantala ES; Hernberg MM; Piperno-Neumann S; Grossniklaus HE; Kivelä TT
    Prog Retin Eye Res; 2022 Sep; 90():101041. PubMed ID: 34999237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors of survival in metastatic uveal melanoma.
    Lorenzo D; Piulats JM; Ochoa M; Arias L; Gutiérrez C; Català J; Cobos E; Garcia-Bru P; Dias B; Padrón-Pérez N; Caminal JM
    Jpn J Ophthalmol; 2019 Mar; 63(2):197-209. PubMed ID: 30796549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.
    Eldredge-Hindy H; Ohri N; Anne PR; Eschelman D; Gonsalves C; Intenzo C; Bar-Ad V; Dicker A; Doyle L; Li J; Sato T
    Am J Clin Oncol; 2016 Apr; 39(2):189-95. PubMed ID: 24441583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning models demonstrate that clinicopathologic variables are comparable to gene expression prognostic signature in predicting survival in uveal melanoma.
    Donizy P; Krzyzinski M; Markiewicz A; Karpinski P; Kotowski K; Kowalik A; Orlowska-Heitzman J; Romanowska-Dixon B; Biecek P; Hoang MP
    Eur J Cancer; 2022 Oct; 174():251-260. PubMed ID: 36067618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases.
    Ludwig J; Haubold J; Heusner TA; Bauer S; Siveke JT; Richly H; Wetter A; Umutlu L; Theysohn JM
    Rofo; 2021 Jun; 193(6):683-691. PubMed ID: 33348383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma.
    Yamamoto A; Chervoneva I; Sullivan KL; Eschelman DJ; Gonsalves CF; Mastrangelo MJ; Berd D; Shields JA; Shields CL; Terai M; Sato T
    Radiology; 2009 Jul; 252(1):290-8. PubMed ID: 19561263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma.
    Lorenzo D; Ochoa M; Piulats JM; Gutiérrez C; Arias L; Català J; Grau M; Peñafiel J; Cobos E; Garcia-Bru P; Rubio MJ; Padrón-Pérez N; Dias B; Pera J; Caminal JM
    Cancer Res Treat; 2018 Oct; 50(4):1130-1139. PubMed ID: 29198096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Prognostic Nomogram for Liver Metastasis of Uveal Melanoma Patients Selected by Liver MRI.
    Mariani P; Dureau S; Savignoni A; Rouic LL; Levy-Gabriel C; Piperno-Neumann S; Rodrigues MJ; Desjardins L; Cassoux N; Servois V
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population.
    Shibayama Y; Namikawa K; Sone M; Takahashi A; Tsutsumida A; Sugawara S; Arai Y; Aihara Y; Suzuki S; Nakayama J; Imafuku S; Yamazaki N
    Int J Clin Oncol; 2017 Jun; 22(3):577-584. PubMed ID: 28144882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of liver metastases from uveal melanoma.
    Rivoire M; Kodjikian L; Baldo S; Kaemmerlen P; Négrier S; Grange JD
    Ann Surg Oncol; 2005 Jun; 12(6):422-8. PubMed ID: 15886904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver function tests in metastatic uveal melanoma.
    Kaiserman I; Amer R; Pe'er J
    Am J Ophthalmol; 2004 Feb; 137(2):236-43. PubMed ID: 14962411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
    Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
    Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening. A comparison with liver function tests.
    Missotten GS; Korse CM; van Dehn C; Linders TC; Keunen JE; Jager MJ; Bonfrer JM
    Tumour Biol; 2007; 28(2):63-9. PubMed ID: 17264538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
    Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H
    J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of liver metastases from uveal melanoma: a retrospective single-center analysis.
    Yang XY; Xie F; Tao R; Li AJ; Wu MC
    Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):602-6. PubMed ID: 24322745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.